However, BCG therapy triggers the release of cytokines (IL-1β, IL-6, IL-8, granulocyte-macrophage colony-stimulating factor -GM-CSF- and TNF-α), which induce a rapid and abundant infiltration of neutrophils into the bladder with a cytotoxic and anti-tumor phenotype [33]. Here, CSF2 is linked to neoplasm.